FALLS CHURCH, VA – (June 10, 2013) – John Deeken, MD, will be joining the Inova Comprehensive Cancer & Research Institute (ICCRI ) as the Associate Director of Clinical Research & Medical Oncology. In this role, Dr. Deeken will work with John E. Niederhuber, MD, CEO and Director of the ICCRI and Inova administration to build a strong program in medical oncology and organ site specific multispecialty cancer clinical programs. Dr. Deeken will have responsibility for leading medical oncology as a service line across the Inova Health System.
“With Dr. Deeken’s leadership, we will bring cancer care at Inova to the next level,” says Susan Carroll, Vice President of Oncology Service Line at Inova, “His clinical experience coupled with his stellar bedside manner will benefit our patients and the future of cancer care at Inova tremendously.”
Dr. Deeken brings to the ICCRI a strong background in Pharmacogenomics and in early phase clinical trials research. He will serve as Associate Director for Clinical Research for the ICCRI and will work with ICCRI leadership to develop and manage the cancer center clinical trial infrastructure, co-direct the contracting and regulatory approval process for clinical trials research and develop outside collaborations for early phase trials. Dr. Deeken has also been named a Fellow of the Inova Translational Medicine Institute (ITMI) where he will help bring genomic-based personalized therapy into the clinic for cancer patients.
“Dr. Deeken is just the person I was searching for,” said John E. Niederhuber, MD, CEO & Director of the Inova Comprehensive Cancer and Research Institute and CEO of the Inova Translational Medicine Institute. “John has a depth of experience in early phase clinical research and shares my strong belief that in the near future we will study each patient genomically to be confident we are giving the right drug at the right dose to treat our cancer patients.”
Dr. Deeken joins Inova from the Georgetown Lombardi Cancer Center where he served as the Director of the Head and Neck Medical Oncology Clinic and led an active research laboratory. He completed his medical degree at the Georgetown University Medical School and residency in Internal Medicine at Georgetown University Hospital. He completed his training in medical oncology at the National Cancer Institute, studying pharmacogenetics and cancer drug resistance under the mentorship of Dr. Susan Bates.
Media Contact: Allison Kenty, 703-504-3840
# # #